August 20, 2021
Sponsored by Caliper
When it comes to regulating CBD, the FDA has prioritized pharmaceutical monopoly over public health, leaving the consuming public and honest brands to fend for themselves. And with its recent rejection of “full spectrum” New Dietary Ingredient Notifications, the Agency has only pushed its head further into the sand. Join Justin Singer, CEO & Co-Founder of Caliper Foods, for this complimentary webinar, where he’ll review how we got here, and what’s next for a category that’s waiting—and waiting—for responsible unlock.
Don’t miss out - register today!
In this webinar, you’ll learn:
A history of the FDA and the cannabis industry
Recent FDA cannabis regulatory guidance
What your brand can do to prepare for the future
Where the industry is headed
Content Marketing Director, Informa Markets Health & Nutrition
CEO & Co-Founder, Caliper Foods
Justin Singer is the CEO and co-founder of Caliper Foods, parent company to Caliper Ingredients. Prior to founding Caliper, Justin spent four years teaching innovation theory and high-growth entrepreneurship at the School of Engineering at Columbia University. He began his career as an investor with IA Ventures, a seed-stage venture capital firm in New York City. Justin holds an MBA in finance from Columbia Business School, a JD in telecommunications law from Columbia Law School and a BBA in operations management from the University of Michigan Ross School of Business.
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023